Location: Home
  • search
  • go
  • Relate News
  • 1/14/2020HitGen Enters into DEL-Based Drug Discovery Partnership with Kymera
  • 1/14/2020Chi-Med Initiates a PII Trial of Surufatinib in Combo with Toripalimab...
  • 1/13/2020BeiGene In-licences Candidates from EUSA Pharma
  • 1/13/2020NMPA Issues Notice on Matters Relating to API Registration Dossier
  • 1/13/2020HRA Pharma Expands in China with Joint Venture
  • 1/11/2020Recent Executive Moves
  • 1/11/2020NMPA Clears Phase 3 Trial for SB12, Samsung Bioepis' Biosimilar Eculiz...
  • 1/11/2020Eisai Launches Anticancer Agent Halaven in China
  • 1/10/2020PPD Expanding Capabilities in China
  • 1/10/2020Shield Therapeutics Licenses China Right of Lead Product to Ask Pharma
  • 1/10/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • 1/10/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • 1/10/2020NMPA Deputy Commissioner Meets with PMDA Chief Executive
  • 1/8/2020Adagene Snags $69M to Advance Cancer Pipeline
  • 1/8/2020Targovax and IOVaxis Enters Option Agreement for TG Mutant RAS Vaccine...
  • 1/8/2020CDE Seeks Comments on Guidelines for Generic Drug Research of Paclitax...
  • 1/8/2020NMPA Publishes the List of Reference Formulations for Generic Drug Equ...
  • 1/8/2020HK Researcher Discovers Anticancer NCE Phorbiplatin
  • 1/7/2020Innovent and Sirnaomics Cooperate to Combine Sintilimab and RNAi in th...
  • 1/7/2020Sorrento, Mabpharm File NDA for Infliximab Biosimilar
  • 1/7/2020NMPA Issues Interim Guidelines for Use of Real-World Data to Support D...
  • 1/7/2020NMPA Issues the List of Reference Formulations for Generic Drug Equiva...
  • 1/6/2020Elpiscience Raises $100M to Advance Immunotherapy
  • 1/6/2020GlycoMimetics and Apollomics Agree to Develop and Commercialize Uprole...
  • 1/6/2020Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigen...
  • 1/6/2020Chinese Scientist Extradited to Stand Trial in the US for Plot to Stea...
  • 1/6/2020NHC Introduces the Clinical Guidelines for Primary Liver Cancer
  • 1/6/2020Eisai Launches First-in-Class Anti-epileptic Fycompa in China
  • 1/6/2020Yisheng Biopharma Forms Cancer IO Partnership with Tavotek
  • 1/3/2020Recent Executive Moves
  • Page:281/803 Total number of articles:24088: [First][<<] [279] [280] [281] [282] [283] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group